Erratum: Whitepaper zu Identifikation, Information und Eignungsprüfung von potenziellen Teilnehmern an der Lungenkrebsfrüherkennung in Deutschland
Torsten Blum(MSB Medical School Berlin), Gerald Schmid‐Bindert(Heidelberg University), Martin Reck(German Center for Lung Research), Stefan Andreas, Anton Faron(Ihre-Radiologen), Jens Vogel‐Claussen(Medizinische Hochschule Hannover), Hans Hoffmann(TUM Klinikum), Rudolf Kaaks(German Cancer Research Center), Volker Harth(Universität Hamburg), Ingrid Dänschel(Universitas PGRI Semarang), Alexander Rupp
Cited by 0
Related Papers
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|2.3k
Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial
|The Lancet|2008|1.2k
Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial
|The Lancet Oncology|2014|948